questionsmedicales.fr
Composés chimiques organiques
Amidines
Guanidines
Biguanides
Biguanides : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Biguanides : Questions médicales les plus fréquentes",
"headline": "Biguanides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Biguanides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-17",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Biguanides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Guanidines",
"url": "https://questionsmedicales.fr/mesh/D006146",
"about": {
"@type": "MedicalCondition",
"name": "Guanidines",
"code": {
"@type": "MedicalCode",
"code": "D006146",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.078.370"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Buformine",
"alternateName": "Buformin",
"url": "https://questionsmedicales.fr/mesh/D002026",
"about": {
"@type": "MedicalCondition",
"name": "Buformine",
"code": {
"@type": "MedicalCode",
"code": "D002026",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.078.370.141.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorhexidine",
"alternateName": "Chlorhexidine",
"url": "https://questionsmedicales.fr/mesh/D002710",
"about": {
"@type": "MedicalCondition",
"name": "Chlorhexidine",
"code": {
"@type": "MedicalCode",
"code": "D002710",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.078.370.141.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Metformine",
"alternateName": "Metformin",
"url": "https://questionsmedicales.fr/mesh/D008687",
"about": {
"@type": "MedicalCondition",
"name": "Metformine",
"code": {
"@type": "MedicalCode",
"code": "D008687",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.078.370.141.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phenformine",
"alternateName": "Phenformin",
"url": "https://questionsmedicales.fr/mesh/D010629",
"about": {
"@type": "MedicalCondition",
"name": "Phenformine",
"code": {
"@type": "MedicalCode",
"code": "D010629",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.078.370.141.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Proguanil",
"alternateName": "Proguanil",
"url": "https://questionsmedicales.fr/mesh/D002727",
"about": {
"@type": "MedicalCondition",
"name": "Proguanil",
"code": {
"@type": "MedicalCode",
"code": "D002727",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.078.370.141.710"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Biguanides",
"alternateName": "Biguanides",
"code": {
"@type": "MedicalCode",
"code": "D001645",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Liam Good",
"url": "https://questionsmedicales.fr/author/Liam%20Good",
"affiliation": {
"@type": "Organization",
"name": "Pathobiology and Population Sciences, The Royal Veterinary College, London, England."
}
},
{
"@type": "Person",
"name": "Alan A Rogers",
"url": "https://questionsmedicales.fr/author/Alan%20A%20Rogers",
"affiliation": {
"@type": "Organization",
"name": "Flintshire, North Wales, UK."
}
},
{
"@type": "Person",
"name": "Manuel D Gahete",
"url": "https://questionsmedicales.fr/author/Manuel%20D%20Gahete",
"affiliation": {
"@type": "Organization",
"name": "Maimonides Institute for Biomedical Research of Cordoba, Córdoba, Spain."
}
},
{
"@type": "Person",
"name": "Justo P Castaño",
"url": "https://questionsmedicales.fr/author/Justo%20P%20Casta%C3%B1o",
"affiliation": {
"@type": "Organization",
"name": "Maimonides Institute for Biomedical Research of Cordoba, Córdoba, Spain."
}
},
{
"@type": "Person",
"name": "Raúl M Luque",
"url": "https://questionsmedicales.fr/author/Ra%C3%BAl%20M%20Luque",
"affiliation": {
"@type": "Organization",
"name": "Maimonides Institute for Biomedical Research of Cordoba, Córdoba, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Development of a workflow for the detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from rectal swabs using the spectra VRE medium.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36609280",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12941-023-00552-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "In vitro activity and adaptation strategies of eravacycline in clinical Enterococcus faecium isolates from China.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41429-022-00546-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anticancer Effect of Enterococcus faecium, Isolated from Vaginal Fluid, on Ovarian Cancer Cells",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37525437",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.52547/ibj.3846"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35752376",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijid.2022.06.029"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissemination of Quinupristin-Dalfopristin and Linezolid resistance genes among hospital environmental and healthy volunteer fecal isolates of Enterococcus faecalis and Enterococcus faecium.",
"datePublished": "2022-06-18",
"url": "https://questionsmedicales.fr/article/35716285",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-022-07627-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Amidines",
"item": "https://questionsmedicales.fr/mesh/D000578"
},
{
"@type": "ListItem",
"position": 4,
"name": "Guanidines",
"item": "https://questionsmedicales.fr/mesh/D006146"
},
{
"@type": "ListItem",
"position": 5,
"name": "Biguanides",
"item": "https://questionsmedicales.fr/mesh/D001645"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Biguanides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Biguanides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Biguanides",
"description": "Comment diagnostiquer le diabète de type 2 ?\nQuels tests sont utilisés pour évaluer la résistance à l'insuline ?\nQuels symptômes indiquent un diabète non contrôlé ?\nComment évaluer l'efficacité des biguanides ?\nQuels sont les critères de diagnostic du diabète ?",
"url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Enterococcus+faecium&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Biguanides",
"description": "Quels sont les effets secondaires des biguanides ?\nComment reconnaître une hypoglycémie ?\nQuels symptômes peuvent indiquer une acidose lactique ?\nQuels signes indiquent une mauvaise gestion du diabète ?\nComment les biguanides affectent-ils l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Enterococcus+faecium&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Biguanides",
"description": "Comment prévenir le diabète de type 2 ?\nQuels facteurs de risque sont modifiables ?\nComment le poids corporel influence-t-il le diabète ?\nQuel rôle joue l'activité physique dans la prévention ?\nLes contrôles médicaux réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Enterococcus+faecium&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Biguanides",
"description": "Comment les biguanides agissent-ils ?\nQuels sont les principaux biguanides utilisés ?\nQuand commencer un traitement par biguanides ?\nQuels sont les dosages habituels de metformine ?\nLes biguanides peuvent-ils être combinés avec d'autres médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Enterococcus+faecium&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Biguanides",
"description": "Quelles sont les complications du diabète mal contrôlé ?\nComment prévenir les complications liées au diabète ?\nQuels sont les signes d'une neuropathie diabétique ?\nComment le diabète affecte-t-il la santé rénale ?\nQuels examens sont nécessaires pour surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Enterococcus+faecium&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Biguanides",
"description": "Quels sont les principaux facteurs de risque du diabète ?\nL'hérédité joue-t-elle un rôle dans le diabète ?\nComment le stress influence-t-il le diabète ?\nLe tabagisme est-il un facteur de risque ?\nQuel impact a l'alimentation sur le risque de diabète ?",
"url": "https://questionsmedicales.fr/mesh/D001645?mesh_terms=Enterococcus+faecium&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le diabète de type 2 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests de glycémie, comme la glycémie à jeun ou l'HbA1c."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la résistance à l'insuline ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le test de tolérance au glucose et l'indice HOMA-IR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un diabète non contrôlé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent soif excessive, urination fréquente et fatigue persistante."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des biguanides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction de la glycémie et l'amélioration de l'HbA1c."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic du diabète ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent une glycémie à jeun ≥ 7 mmol/L ou HbA1c ≥ 6,5%."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des biguanides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hypoglycémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent tremblements, sueurs, confusion et palpitations."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une acidose lactique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue extrême, douleurs musculaires et respiration rapide."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une mauvaise gestion du diabète ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des infections fréquentes, des plaies qui guérissent lentement et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment les biguanides affectent-ils l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biguanides peuvent réduire l'appétit, contribuant ainsi à la perte de poids chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir le diabète de type 2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice régulier, aide à prévenir le diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont modifiables ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le manque d'activité physique et une alimentation déséquilibrée sont modifiables."
}
},
{
"@type": "Question",
"name": "Comment le poids corporel influence-t-il le diabète ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de poids augmente la résistance à l'insuline, augmentant le risque de diabète."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'activité physique dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité physique régulière améliore la sensibilité à l'insuline et aide à contrôler le poids."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers aident à détecter précocement le diabète et à gérer les risques."
}
},
{
"@type": "Question",
"name": "Comment les biguanides agissent-ils ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils diminuent la production de glucose par le foie et augmentent la sensibilité à l'insuline."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux biguanides utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La metformine est le biguanide le plus couramment prescrit pour le diabète de type 2."
}
},
{
"@type": "Question",
"name": "Quand commencer un traitement par biguanides ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement commence généralement après un diagnostic de diabète de type 2 et un échec des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les dosages habituels de metformine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les doses varient de 500 mg à 2000 mg par jour, selon la tolérance et la réponse du patient."
}
},
{
"@type": "Question",
"name": "Les biguanides peuvent-ils être combinés avec d'autres médicaments ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être combinés avec d'autres antidiabétiques pour un meilleur contrôle glycémique."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du diabète mal contrôlé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des neuropathies et des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées au diabète ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon contrôle glycémique et des examens réguliers aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une neuropathie diabétique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des picotements, des engourdissements et des douleurs dans les membres."
}
},
{
"@type": "Question",
"name": "Comment le diabète affecte-t-il la santé rénale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète peut entraîner une néphropathie, affectant la fonction rénale et provoquant des complications."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers de la fonction rénale, des pieds et des yeux sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du diabète ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, l'âge avancé, l'hérédité et le mode de vie sédentaire."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans le diabète ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un antécédent familial de diabète augmente le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il le diabète ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut affecter la glycémie et la gestion du diabète, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de diabète et de complications cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quel impact a l'alimentation sur le risque de diabète ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en sucres et en graisses saturées augmente le risque de diabète."
}
}
]
}
]
}
Spectra™ VRE agar (Remel, Lenexa, KS) is a chromogenic agar that is FDA approved for screening patients for VRE colonization. The package insert recommends confirming isolates with identification and ...
Our laboratory sought to develop a workflow to optimize the use of the medium....
We plated 3,815 rectal swabs to the Spectra VRE agar and compared results to traditional identification and susceptibility testing....
Dark blue or purple colonies on the agar demonstrated a sensitivity of 98% and specificity of 85% for detection of VRE faecium, but light blue colonies were significantly less specific for E. faecalis...
We streamlined our workflow to accept dark blue or purple colonies as VRE faecium and plan to perform additional testing only on light blue colonies. Interestingly, higher quantity of growth increased...
Eravacycline (Erava) is a synthetic fluorocycline with potent antimicrobial activity against a wide range of Gram-positive bacteria. This study aimed to investigate the in vitro antimicrobial activity...
Given the association between cervicovaginal microbiota and OVC, we investigated the effect of Enterococcus faecium conditioned medium (CM) on OVC (Caov-4) cells....
CM was obtained from the bacterium E. faecium isolated from the vagina of healthy women. The Caov-4 cells were treated with varying concentrations of CM that comprised co-cultured bacteria with 0.2, 0...
The CM at a concentration of 0.5 OD from the cultured bacteria and incubation time of 48 h showed the highest negative effect on the viability of cancer cells. The CM treatment increased DNA fragmenta...
CM of human-derived E. faecium could have an anticancer effect on OVC cells in a concentration- and time-dependent manner. This study demonstrated that E. faecium secretes anticancer substances into t...
Vancomycin and teicoplanin are glycopeptides with activity against Enterococcus faecium. However, studies on the clinical efficacy of teicoplanin are limited. This study aimed to compare the therapeut...
We identified patients with bloodstream infections prospectively from July 2015 to December 2016 in 14 hospitals as part of a multicenter nationwide surveillance. Patients with E. faecium monomicrobia...
Among 97 patients with E. faecium bacteremia, 33 (34%) were treated with teicoplanin and 64 (66%) with vancomycin. There were no significant differences in 30-day in-hospital mortality (18.2% vs 26.6%...
We found no significant differences in the clinical outcomes. These findings suggest teicoplanin as a useful alternative to vancomycin....
Streptogramins and linezolid are important in the treatment of infections caused by vancomycin-resistant enterococci....
Then, we aimed to evaluate the resistance rates against these drugs and the prevalence of genes involved in hospital environmental and fecal normal-flora isolates of Enterococcus faecalis and Enteroco...
The strains were isolated from the stool samples and hospital environments by culturing on M-Enterococcus (ME) agar, and identified by phenotypic and genotypic microbiological tests. The disk agar dif...
High-level streptogramin resistance rate and high prevalence of resistance genes in enterococci isolated from the stool of healthy persons and the hospital environment indicates the importance of poss...
Multidrug-resistant (MDR) bacteria have become a growing threat to public health. The gram-positive Enterococcus faecium is classified by WHO as a high-priority pathogen among the global priority list...
Enterococcus faecium is a major species in infections by vancomycin-resistant enterococci (VRE). New variants of the pathogen have emerged and become dominant in healthcare settings. Two such examples...
Antimicrobial resistance (AMR) of bacterial pathogens, including enterococci, is a global concern, and plasmids are crucial for spreading and maintaining AMR genes. Plasmids with linear topology were ...
Vancomycin-resistant enterococci (VRE) are important pathogens categorized as high-priority bacteria in the Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Deve...
A cross-sectional study was conducted during a two-month periods among hospitalized patients in 2017. Rectal swabs were collected from patients admitted to medical and surgical wards in an urban terti...
Sequencing analysis revealed that these strains harbouring numerous resistance genes to glycopeptides (vanC[100%], vex3[100%], vex2[83,33%] and vanG[16,66%]), macrolides, lincosamides, sterptogramine ...
The study reveals the genetic diversity and high pathogenicity of multidrug-resistant Enterococcus faecalis and faecium circulating among hospitalized patients. It underlines the necessity to implemen...
Infections caused by vancomycin-resistant Enterococcus faecium (VREfm) are an important public health threat. VREfm isolates have become increasingly resistant to the front-line antibiotic daptomycin ...